[SSRI resistant depression. Supplementation with noradrenergic pharmaceuticals can be a good alternative].
Bodlund
Owe
O
Institutionen för klinisk vetenskap-psykiatri, Umeå universitet, Sweden. Owe.Bodlund@psychiat.umu.se
Häggström
Lars
L
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D000077593:Reboxetine; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D018759:Adrenergic Uptake Inhibitors; D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D009025:Morpholines; D000077593:Reboxetine; D017367:Selective Serotonin Reuptake Inhibitors
Vid SSRI-resistent depression. Tillägg av noradrenergt verkande farmaka kan vara ett bra alternativ.